Epiregulin as a marker for the initial steps of ovarian cancer development
- Abraham Amsterdam*
- , Elias Shezen
- , Calanit Raanan
- , Yasmin Slilat
- , Alon Ben-Arie
- , Diana Prus
- , Letizia Schreiber
*Corresponding author for this work
- Weizmann Institute of Science
- Kaplan Medical Center Israel
- Hadassah University Medical Centre
- Edith Wolfson Medical Center Israel
Research output: Contribution to journal › Article › peer-review
20
Scopus
citations